Schottelius M - Search Results

1

Pharmacophoric modifications lead to superpotent αvβ3 integrin ligands with suppressed α5β1 activity.

Neubauer S, Rechenmacher F, Brimioulle R, Di Leva FS, Bochen A, Sobahi TR, Schottelius M, Novellino E, Mas-Moruno C, Marinelli L, Kessler H. Neubauer S, et al. Among authors: schottelius m. J Med Chem. 2014 Apr 24;57(8):3410-7. doi: 10.1021/jm500092w. Epub 2014 Apr 8. J Med Chem. 2014. PMID: 24654918

2

Influence of corticosteroid treatment on CXCR4 expression in DLBCL.

Martin S, Viertl D, Janz A, Habringer S, Keller U, Schottelius M. Martin S, et al. Among authors: schottelius m. EJNMMI Res. 2023 May 10;13(1):40. doi: 10.1186/s13550-023-00993-4. EJNMMI Res. 2023. PMID: 37162652 Free PMC article.

3

Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs.

Poethko T, Schottelius M, Thumshirn G, Hersel U, Herz M, Henriksen G, Kessler H, Schwaiger M, Wester HJ. Poethko T, et al. Among authors: schottelius m. J Nucl Med. 2004 May;45(5):892-902. J Nucl Med. 2004. PMID: 15136641 Free article.

4

First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.

Schottelius M, Poethko T, Herz M, Reubi JC, Kessler H, Schwaiger M, Wester HJ. Schottelius M, et al. Clin Cancer Res. 2004 Jun 1;10(11):3593-606. doi: 10.1158/1078-0432.CCR-03-0359. Clin Cancer Res. 2004. PMID: 15173065

5

N-terminal sugar conjugation and C-terminal Thr-for-Thr(ol) exchange in radioiodinated Tyr3-octreotide: effect on cellular ligand trafficking in vitro and tumor accumulation in vivo.

Schottelius M, Reubi JC, Eltschinger V, Schwaiger M, Wester HJ. Schottelius M, et al. J Med Chem. 2005 Apr 21;48(8):2778-89. doi: 10.1021/jm040794i. J Med Chem. 2005. PMID: 15828816

6

Synthesis of novel 1,4,7,10-tetraazacyclodecane-1,4,7,10-tetraacetic acid (DOTA) derivatives for chemoselective attachment to unprotected polyfunctionalized compounds.

Knör S, Modlinger A, Poethko T, Schottelius M, Wester HJ, Kessler H. Knör S, et al. Among authors: schottelius m. Chemistry. 2007;13(21):6082-90. doi: 10.1002/chem.200700231. Chemistry. 2007. PMID: 17503419

7

Ligands for mapping alphavbeta3-integrin expression in vivo.

Schottelius M, Laufer B, Kessler H, Wester HJ. Schottelius M, et al. Acc Chem Res. 2009 Jul 21;42(7):969-80. doi: 10.1021/ar800243b. Acc Chem Res. 2009. PMID: 19489579

8

PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent.

Gourni E, Demmer O, Schottelius M, D'Alessandria C, Schulz S, Dijkgraaf I, Schumacher U, Schwaiger M, Kessler H, Wester HJ. Gourni E, et al. Among authors: schottelius m. J Nucl Med. 2011 Nov;52(11):1803-10. doi: 10.2967/jnumed.111.098798. J Nucl Med. 2011. PMID: 22045709 Free article.

9

A conformationally frozen peptoid boosts CXCR4 affinity and anti-HIV activity.

Demmer O, Frank AO, Hagn F, Schottelius M, Marinelli L, Cosconati S, Brack-Werner R, Kremb S, Wester HJ, Kessler H. Demmer O, et al. Among authors: schottelius m. Angew Chem Int Ed Engl. 2012 Aug 6;51(32):8110-3. doi: 10.1002/anie.201202090. Epub 2012 Jul 3. Angew Chem Int Ed Engl. 2012. PMID: 22760863 No abstract available.

10

Orthogonally protected artificial amino acid as tripod ligand for automated peptide synthesis and labeling with [(99m)Tc(OH(2))(3)(CO)(3)](+).

Shen Y, Schottelius M, Zelenka K, De Simone M, Pohle K, Kessler H, Wester HJ, Schmutz P, Alberto R. Shen Y, et al. Among authors: schottelius m. Bioconjug Chem. 2013 Jan 16;24(1):26-35. doi: 10.1021/bc3003327. Epub 2012 Dec 26. Bioconjug Chem. 2013. PMID: 23237229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters